Genesis Healthcare Inc. (NYSE: GEN) is 57.83% higher on its value in year-to-date trading and has touched a low of $0.40 and a high of $1.86 in the current 52-week trading range. The GEN stock was last observed hovering at around $0.68 in the last trading session, with the day’s gains setting it 0.08% off its average median price target of $0.54 for the next 12 months. It is also -33.33% off the consensus price target high of $0.57 offered by 2 analysts, but current levels are -52.0% lower than the price target low of $0.50 for the same period.
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free. .
Currently trading at $0.76, the stock is 37.84% and 47.82% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 8.24 million and changing 13.33% at the moment leaves the stock 13.54% off its SMA200. GEN registered -49.34% loss for a year compared to 6-month loss of 2.38%. The firm has a 50-day simple moving average (SMA 50) of $0.5421 and a 200-day simple moving average (SMA200) of $0.6118.
The stock witnessed a 34.71% gain in the last 1 month and extending the period to 3 months gives it a 46.41%, and is 39.85% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 9.37% over the week and 10.48% over the month.
Genesis Healthcare Inc. (GEN) has around 55000 employees, a market worth around $125.51M and $4.12B in sales. Profit margin for the company is -1.50%. Distance from 52-week low is 90.77% and -58.86% from its 52-week high. The company has generated returns on investments over the last 12 months (20.10%).
Genesis Healthcare Inc. (GEN) Analyst Forecasts
Analyst recommendations provided by FactSet shows that the consensus forecast for Genesis Healthcare Inc. (GEN) is a “Hold”. 2 analysts offering their recommendations for the stock have an average rating of 3.00, where 2 rate it as a Hold and 0 think it is a “Overweight”. 0 of the analysts rate the stock as a “Buy”. 0 analysts have rated the stock as a Sell or Underperform.
Genesis Healthcare Inc. is expected to release its quarterly report on 05/13/2021 and quarterly earnings per share for the current quarter are estimated at -$0.13 with sales reaching $923.49M over the same period.The EPS is expected to grow by 103.80% this year, but quarterly earnings will post -14.30% year-over-year. Quarterly sales are estimated to shrink -18.70% in year-over-year returns.
Genesis Healthcare Inc. (GEN) Top Institutional Holders
65 institutions hold shares in Genesis Healthcare Inc. (GEN), with 47.16M shares held by insiders accounting for 42.34% while institutional investors hold 39.53% of the company’s shares. The shares outstanding are 113.15M, and float is at 63.80M with Short Float at 0.84%. Institutions hold 22.79% of the Float.
The top institutional shareholder in the company is Vanguard Group, Inc. (The) with over 4.74 million shares valued at $2.58 million. The investor’s holdings represent 4.28% of the GEN Shares outstanding. As of Sep 29, 2020, the second largest holder is Renaissance Technologies, LLC with 3.82 million shares valued at $2.08 million to account for 3.46% of the shares outstanding. The other top investors are First Washington Corporation which holds 3.04 million shares representing 2.75% and valued at over $1.66 million, while V3 Capital Management, L.P. holds 2.71% of the shares totaling 3.0 million with a market value of $1.63 million.
Genesis Healthcare Inc. (GEN) Insider Activity
A total of 2 insider transactions have happened at Genesis Healthcare Inc. (GEN) in the last six months, with sales accounting for 1 and purchases happening 1 times. The most recent transaction is an insider sale by DiVittorio Thomas, the company’s EVP and CFO. SEC filings show that DiVittorio Thomas sold 6,671 shares of the company’s common stock on Jun 03 at a price of $0.96 per share for a total of $6371.0. Following the sale, the insider now owns 1.05 million shares.
Genesis Healthcare Inc. disclosed in a document filed with the SEC on Jun 03 that Reifsnyder JoAnne Susan (EVP and Chief Nursing Officer) sold a total of 5,313 shares of the company’s common stock. The trade occurred on Jun 03 and was made at $0.96 per share for $5074.0. Following the transaction, the insider now directly holds 0.65 million shares of the GEN stock.
Still, SEC filings show that on Jun 03, Young Stephen Scott (SVP and Treasurer) disposed off 3,315 shares at an average price of $0.96 for $3166.0. The insider now directly holds 415,226 shares of Genesis Healthcare Inc. (GEN).
Genesis Healthcare Inc. (GEN): Who are the competitors?
The company’s main competitors (and peers) include Five Star Senior Living Inc. (FVE) that is trading 20.03% up over the past 12 months. The Ensign Group Inc. (ENSG) is 78.99% up on the 1-year trading charts. Short interest in the company’s stock has fallen -35.64% from the last report on Nov 29, 2020 to stand at a total of 0.73 million short shares sold with a short interest ratio of 0.36.